1. Recurrence of Symptoms Following Cryptococcal Meningitis: Characterizing a Diagnostic Conundrum With Multiple Etiologies.
- Author
-
Bahr, Nathan, Skipper, Caleb, Huppler-Hullsiek, Kathy, Ssebambulidde, Kenneth, Morawski, Bozena, Engen, Nicole, Nuwagira, Edwin, Quinn, Carson, Ramachandran, Prashanth, Evans, Emily, Lofgren, Sarah, Abassi, Mahsa, Muzoora, Conrad, Meya, David, Rhein, Joshua, Boulware, David, and Wilson, Michael
- Subjects
cryptococcal meningitis ,cryptococcosis ,immune reconstitution inflammatory syndrome ,meningitis ,relapse ,Humans ,Meningitis ,Cryptococcal ,AIDS-Related Opportunistic Infections ,HIV Infections ,Antifungal Agents ,Recurrence - Abstract
BACKGROUND: Cryptococcal meningitis is a common cause of AIDS-related mortality. Although symptom recurrence after initial treatment is common, the etiology is often difficult to decipher. We sought to summarize characteristics, etiologies, and outcomes among persons with second-episode symptomatic recurrence. METHODS: We prospectively enrolled Ugandans with cryptococcal meningitis and obtained patient characteristics, antiretroviral therapy (ART) and cryptococcosis histories, clinical outcomes, and cerebrospinal fluid (CSF) analysis results. We independently adjudicated cases of second-episode meningitis to categorize patients as (1) microbiological relapse, (2) paradoxical immune reconstitution inflammatory syndrome (IRIS), (3) persistent elevated intracranial pressure (ICP) only, or (4) persistent symptoms only, along with controls of primary cryptococcal meningitis. We compared groups with chi-square or Kruskal-Wallis tests as appropriate. RESULTS: 724 participants were included (n = 607 primary episode, 81 relapse, 28 paradoxical IRIS, 2 persistently elevated ICP, 6 persistent symptoms). Participants with culture-positive relapse had lower CD4 (25 cells/μL; IQR: 9-76) and lower CSF white blood cell (WBC; 4 cells/μL; IQR: 4-85) counts than paradoxical IRIS (CD4: 78 cells/μL; IQR: 47-142; WBC: 45 cells/μL; IQR: 8-128). Among those with CSF WBC
- Published
- 2023